Resistance mechanisms in KRAS-G12C-mutated cancer

被引：0
|
作者：
Gassa, Asmae [1 ]
Ozkan, Filiz [2 ,3 ]
Ast, David [4 ]
Wahlers, Thorsten [1 ]
Bruns, Christiane [5 ]
Alakus, Hakan [5 ]
机构：
[1] Univ Klinikum Koln AoR, Klin & Poliklin Herzchirurg Herzchirurg Intens Me, Kerpener Str 62, D-50937 Cologne, Germany
[2] Univ Med Mannheim, Sekt Pneumol, Med Klin 1, Mannheim, Germany
[3] Ohio State Univ, James Comprehens Canc Ctr, Columbus, OH 43210 USA
[4] Univ Cologne, Inst Pathol, Univ Klinikum Koln AoR, Mol,Pathol, Cologne, Germany
[5] Univ Klinikum Koln AoR, Klin & Poliklin Allgemein Viszeral & Tumorchirug, Cologne, Germany
来源：
ONKOLOGE | 2021年 / 27卷 / 12期
关键词：
D O I：
10.1007/s00761-021-01038-y
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1243 / 1244
页数：2
相关论文
共 50 条
  • [1] Resistenzmechanismen beim KRAS-G12C-mutierten KarzinomResistance mechanisms in KRAS-G12C-mutated cancer
    Asmae Gassa
    Filiz Özkan
    David Ast
    Thorsten Wahlers
    Christiane Bruns
    Hakan Alakus
    Der Onkologe, 2021, 27 (12): : 1243 - 1244
  • [2] Role of AXL activation on adaptive resistance to KRAS-G12C inhibitors in KRAS-G12C-mutated non-small cell lung cancer
    Yamada, T.
    Morimoto, K.
    Hirai, S.
    Katayama, Y.
    Kunimasa, K.
    Sasaki, T.
    Nishida, M.
    Watanabe, S.
    Shiotsu, S.
    Uehara, H.
    Takayama, K.
    ANNALS OF ONCOLOGY, 2023, 34 : S194 - S194
  • [3] Mechanisms of Resistance to KRAS G12C Inhibitors
    Ambrogio, C.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S96 - S96
  • [4] Mechanisms of acquired resistance to KRAS G12C inhibition in cancer.
    Awad, Mark
    Liu, Shengwu
    Arbour, Kathryn
    Zhu, Viola
    Johnson, Melissa
    Heist, Rebecca
    Patil, Tejas
    Riely, Gregory
    Jacobson, Joseph
    Dilly, Julien
    Yang, Xiaoping
    Persky, Nicole
    Root, David
    Sholl, Lynette
    Lim, Lee
    Garg, Kavita
    Li, Mark
    Engstrom, Lars
    Waters, Laura
    Lawson, J. David
    Olson, Peter
    Christensen, James
    Lito, Piro
    Ou, Sai-Hong Inatius
    Janne, Pasi
    Aguirre, Andrew
    CANCER RESEARCH, 2021, 81 (13)
  • [5] Oncogenic non-G12C KRAS mutations in KRAS G12C mutated lung adenocarcinomas in TRACERx and GENIE: A reservoir for intrinsic resistance to KRAS G12C inhibitors
    Marinelli, D.
    Pisegna, S.
    Giammaruco, M.
    Chesi, P.
    Mammone, G.
    Ceddia, S.
    Gazzaniga, P.
    Cortesi, E.
    Gelibter, A. J.
    ANNALS OF ONCOLOGY, 2021, 32 : S1345 - S1346
  • [6] Sotorasib in KRAS p.G12C-Mutated Advanced Pancreatic Cancer
    Strickler, J. H.
    Satake, H.
    George, T. J.
    Yaeger, R.
    Hollebecque, A.
    Garrido-Laguna, I.
    Schuler, M.
    Burns, T. F.
    Coveler, A. L.
    Falchook, G. S.
    Vincent, M.
    Sunakawa, Y.
    Dahan, L.
    Bajor, D.
    Rha, S. -Y.
    Lemech, C.
    Juric, D.
    Rehn, M.
    Ngarmchamnanrith, G.
    Jafarinasabian, P.
    Tran, Q.
    Hong, D. S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (01): : 33 - 43
  • [7] Sotorasib for KRAS p.G12C-mutated advanced pancreatic cancer
    Baker, Holly
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2023, 8 (03): : 213 - 213
  • [8] Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C
    Yaeger, Rona
    Weiss, Jared
    Pelster, Meredith S.
    Spira, Alexander, I
    Barve, Minal
    Ou, Sai-Hong, I
    Leal, Ticiana A.
    Bekaii-Saab, Tanios S.
    Paweletz, Cloud P.
    Heavey, Grace A.
    Christensen, James G.
    Velastegui, Karen
    Kheoh, Thian
    Der-Torossian, Hirak
    Klempner, Samuel J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (01): : 44 - 54
  • [9] Intrinsic resistance mechanisms to mutant KRAS specific inhibitor in KRAS mutated colorectal cancer
    Maruyama, Kohei
    Suzuki, Mai
    Ohhara, Tomoko
    Nagayama, Satoshi
    Fujita, Naoya
    Katayama, Ryohei
    CANCER SCIENCE, 2023, 114 : 1210 - 1210
  • [10] Intrinsic resistance mechanisms to mutant KRAS specific inhibitor in KRAS mutated colorectal cancer
    Maruyama, Kohei
    Suzuki, Mai
    Ohhara, Tomoko
    Nagayama, Satoshi
    Fujita, Naoya
    Katayama, Ryohei
    CANCER SCIENCE, 2023, 114 : 783 - 783
12345